StonyLab tailors each project to our customers’ needs, using existing synthesis pathways or developing new, more robust routes to ensure fast and effective completion of each project. Our experience includes, but is not limited to:

- Biologically active compounds
- Asymmetric synthesis and chiral separation
- Multi-step synthetic and medicinal chemistry
- Drug metabolites and API impurities
- Photochemistry and pressure reactions
- Stable isotopes including deuterium, 13C and 15N
- Toxic compounds and potent substances
- Natural products including carbohydrates and steroids
- Organometallic chemistry
- Highly pure polycyclic aromatic hydrocarbons for material science
- Peptide and polypeptide synthesis
- Bioconjugate chemistry
- Linker chemistry
- Antibody drug conjugates (ADCs)

As well as development level synthesis, StonyLab has the capability to scale up multi-step procedures for the manufacture of batches, to both GLP (for toxicity studies) and GMP standard (for clinical trials).